Evidence map›Paper›PMID 40874614›Full record

ArticlemBio2025

Inhibitory effect of capsule on natural transformation of

Sheya Xiao Ma, Hannes Eichner, Michael Cammer, Jeffrey N Weiser

Abstract read
In one paragraph

Article in mBio, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Development of a GFP-labeledApplied and environmental microbiology · 2026
    Article
  2. Article
  3. Bacterial and host factors affecting acquisition ofbioRxiv : the preprint server for biology · 2026
    Article
  4. Article
  5. International journal of molecular sciences · 2025
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Sheya Xiao MaDepartment of Microbiology, New York University Grossman School of Medicine, New York, New York, USA.ORCID 0009-0009-2268-2616
Hannes EichnerDepartment of Microbiology, New York University Grossman School of Medicine, New York, New York, USA.ORCID 0000-0002-1724-420X
Michael CammerNYU Langone Health Microscopy Laboratory, New York University Grossman School of Medicine, New York, New York, USA.
Jeffrey N WeiserDepartment of Microbiology, New York University Grossman School of Medicine, New York, New York, USA.ORCID 0000-0001-7168-8090

Funding

Vaccine FacilityP30CA016087 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI ADRIANA HEGUY · 1985 to 2026
$83.1M
Mechanisms of Pneumococcal Persistence During CarriageR37AI038446 · NIAID · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI Jeffrey Neal Weiser · 2020 to 2026
$3.8M
Targeting Pneumococcal TransmissionR01AI150893 · NIAID · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI WEISER, JEFFREY NEAL · 2020 to 2024
$3.3M
NCI NIH HHS P30 CA016087NIAID NIH HHS R01 AI150893NIAID NIH HHS R37 AI038446NIH HHS R01AI150893, R37AI038446
6 · The paper itself

Abstract

The capsule of

Indexed as

Bacterial CapsulesStreptococcus pneumoniaeTransformation, BacterialBacterial ProteinsFimbriae, BacterialGene Expression Regulation, BacterialRegulonSerogroupBacterial Proteinscapsulecompetencecompetence pilusgenetic transformationStreptococcus pneumoniae

Identifiers

PMID40874614
PMCPMC12506006

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.